Calidi Biotherapeutics, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Calidi Biotherapeutics, Inc. (CLDI) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $4.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-27
- Calidi Biotherapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $4.80M, a 12.73% decline from fiscal 2024.
- Calidi Biotherapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $5.50M, a 33.73% decline from fiscal 2023.
- Calidi Biotherapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $8.30M, a 36.07% increase from fiscal 2022.
- Calidi Biotherapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $6.10M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $4.80M 10-K · filed 2026-03-27 | ||
| 2024-12-31 | $5.50M 10-K · filed 2026-03-27 | ||
| 2023-12-31 | $8.30M 10-K · filed 2025-03-31 | ||
| 2022-12-31 | $6.10M 10-K · filed 2024-03-15 | $1.13M 10-K · filed 2023-03-31 | |
| 2021-12-31 | $457.38K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |